BioVentures Investors Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 8
Professionals
  • Investments
  • 65
  • Portfolio
  • 11
  • Exits
  • 24
Exits

BioVentures Investors General Information

Description

BioVentures Investors is a venture capital investment firm which specializes in seed, early stage and later stage investments. It prefers to invest in the medical devices, diagnostics and similar new commercial technology sectors, collectively known as Medtech. The firm was founded in 1998 and is based in Wellesley, Massachusetts.

Contact Information

Year Founded
1998
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 70 Walnut Street
  • Suite 302
  • Wellesley, MA 02481
  • United States
+1 (617) 000-0000

BioVentures Investors Investments (65)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Sonomotion 12-Nov-2019 Later Stage VC 0000 Surgical Devices Generating Revenue
0000000000 24-Sep-2019 00000 00000 0000 Monitoring Equipment Generating Revenue 0000 00000000 00
00000000 000000000 16-Oct-2018 00000 00000 0000 Biotechnology Clinical Trials - Phase 2 0000 00000000 00
0000000000 06-Sep-2018 00000 00000 00.000 Other Healthcare Technology Systems Generating Revenue
000000 (0000000000 18-Jul-2018 0000 00000 00.00 Electronics (B2C) Generating Revenue
0000000 0000000000 10-Jul-2018 00000 00000 00.000 Electronic Equipment and Instruments Generating Revenue
0000000000 12-Feb-2018 00000 00000 0000 Monitoring Equipment Generating Revenue 0000 00000000 00
0000000000 07-Apr-2017 00000 00000 00.00 Surgical Devices Generating Revenue
CoNextions 28-Mar-2017 Later Stage VC 00.000 Surgical Devices Generating Revenue
POC Medical Systems 10-Jan-2017 Early Stage VC 0000 Diagnostic Equipment Out of Business 0000 00000000 00
You’re viewing 10 of 65 investments. Get the full list »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioVentures Investors Exits (24)

Company Name Exit Date Exit Type Exit Size
Hydra Biosciences 01-Dec-2018 Merger/Acquisition 000.00
000 000000 30-Jun-2017 000 00 00000000
0000000 000000000 12-Oct-2015 000000000000000000
0000 0000 0000000 01-Nov-2014 000 00 00000000
000000 00000000000 01-Apr-2013 000 00 00000000
000000 00000000000 21-Mar-2013 000 0000
0000000 0000000000 16-Nov-2012 0000000000
0000000000 00 18-Jun-2012 0000000000: 000000
Claros Diagnostics 13-Oct-2011 Merger/Acquisition 000.00
Olympus Endo Technology America 01-Jul-2011 Merger/Acquisition 0000
You’re viewing 10 of 24 exits. Get the full list »

BioVentures Investors Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore BioVentures Investors‘s full profile, request access.

Request a free trial

BioVentures Investors Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

BioVentures Investors Team (11)

Name Title Deals Funds Boards Office
Jeffrey Barnes Managing Director 0 Wellesley, MA
Marc Goldberg JD Co-Founder & Managing Partner 00 0 0 Wellesley, MA
Walter Gilbert Ph.D General Partner 0 0 0 Wellesley, MA
Tony Lyons General Partner, Special Opportunity Fund Wellesley, MA
Peter Feinstein Co-Founder & Venture Partner 0 0 0 Wellesley, MA
You’re viewing 5 of 11 team members. Get the full list »

BioVentures Investors Co-Investors (35)

Name With Exits Lead Partner Series Industry
Aperture Venture Partners 1 0 Series chart Industry bar
Life Sciences Partners 0 0 Series chart Industry bar
Lumira Ventures 0 0 Series chart Industry bar
SV Health Investors 0 0 Series chart Industry bar
Seroba Life Sciences 0 0 Series chart Industry bar
You’re viewing 5 of 35 co-investors. Get the full list »